CTRI/2024/06/069661尚未招募3 期
Role of prophylactic levetiracetam in CNS Tuberculosis: A randomized double-blind placebo-controlled study - NI
GB Pant Institute of Post Graduate Medical Education and Research, New Delhi 1100020 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with CNS Tuberculosis will be included fulfilling following criteria:
- •1. Within 6 months of diagnosis
- •2. At high risk for seizures that will include one or more of the following:
- •A. Grade II and III MRC stage
- •B. Epileptiform discharges on EEG
- •C. Abnormal neuroimaging (supra-tentorial tuberculoma or abscess or leptomeningeal enhancement or cortical infarct or hydrocephalus)
排除标准
- •1. Age less than or equal to 12 years
- •2. Diagnosed case of seizure disorder or taking anti-seizure medication
- •3. Advanced kidney or liver disease
- •4. Pregnancy or breastfeeding
- •5. Contraindication to the use of Levetiracetam (significant neuropsychiatric symptoms,
- •depression, psychosis)
研究者
相似试验
尚未招募
3 期
Prophylactic antiseizure medication in post cardiac arrest childreCTRI/2024/05/067855All India Institute of Medical Sciences Raipur
尚未招募
3 期
Homoeopathy in Prevention of TuberculosisCTRI/2024/06/069488Central Council for Research in Homoeopathy
已完成
2 期
Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected PatientsToxoplasmosis, CerebralHIV InfectionsNCT00000643National Institute of Allergy and Infectious Diseases (NIAID)150
已完成
不适用
To investigate the effects of levetiracetam on the rehabilitation outcome in patients with cerebral infarctiocerebral infarctionJPRN-UMIN000033761Yamanashi Rehabilitation Hospital30
已完成
4 期
Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure PreventionTraumatic Brain InjurySubarachnoid HemorrhageNCT00618436University of Cincinnati52